The Industrial Phase-Transfer Catalysis Experts

PTC Tip of the Month E-Newsletter

PTC Reaction of the Month - January 2026

PTC Capture and Reaction of Carbon Dioxide to Cyclic Carbonates

By Marc Halpern, the leading expert in industrial phase-transfer catalysis.

Over the years, this newsletter has discussed several PTC or PTC-like systems designed for reacting carbon dioxide with epoxides to form cyclic carbonates, often using tetra-n-butylammonium salts. Examples include:

 

A recently published patent application adds a new perspective:

Lee, H. J.; Lee, U.; Yoo, C.-J.; Won, D.; Kim, K.; Kim, J. (Korea Institute of Science and Technology), US Patent Application 2026/0008765, 08-Jan-2026.

This patent describes a method for capturing carbon dioxide directly from ambient air using a diamine solution in diglyme, and then reacting the captured CO2 with an epoxide (specifically, propylene oxide) in the presence of a quaternary ammonium halide catalyst to form a cyclic carbonate, propylene carbonate. Notably, the process avoids the energy-intensive CO2 stripping step typically required in amine capture systems that the inventors state use 80% of the energy in the processes reported in prior art. The inventors appear to suggest that this new process is less energy intensive.

In Example 2 of the patent, the inventors describe a reaction in which propylene oxide (4.5 g, 77.5 mmol) is added to a diglyme solution containing a diamine that has previously captured CO2 from air containing 430 ppm CO2. A quaternary ammonium bromide salt (0.5 mmol) is used as the catalyst, and the mixture is reacted at 80 °C for 4 hours under 10 bar of nitrogen. Yields of propylene carbonate are compared across six catalysts:

Table 2 – Reaction of Propylene Oxide with CO2 to Form Propylene Carbonate

Catalyst Yield of Propylene Carbonate (%)
NH4Br   20
Tetramethylammonium Br     0
Cetyl trimethyl ammonium Br   76
Teteraethylammonium Br   17
Tetraproyplammonium Br 100
Tetrabutylammonium Br 100

 

The pattern here is familiar to those of us in phase-transfer catalysis: symmetrical quats with at least 12 carbon atoms (TPAB and TBAB) show optimal reactivity, while TMAB, with its short chains, fails entirely. Surprisingly, even simple ammonium bromide gives 20% yield. CTAB performs modestly at 76%, likely due to its head-and-tail asymmetry and tendency to form micelles. This outcome reinforces a key PTC principle: symmetrical quats with sufficient lipophilicity and proper solubility balance generally excel.

In Example 4, the inventors conduct a similar reaction with the same epoxide (propylene oxide), but this time using tetrabutylammonium salts with different halide counterions: iodide, bromide, and chloride. The solvent is also varied (triglyme or tetraglyme), and the rest of the conditions are held constant.

 Table 4 – Reaction of Propylene Oxide with CO2 Using Tetrabutylammonium Halides

Catalyst  Solvent Yield of Propylene Carbonate (%)
TBAB  Triglyme       93
TBACl  Tetraglyme       86
TBAI  Tetraglyme     100

 

The trend here follows classic expectations from PTC theory: iodide > bromide > chloride in terms of nucleophilicity and catalytic activity. This result is consistent with earlier PTC work, where iodides often outperform due to their superior leaving group abilities and their ability to stabilize transition states.

As someone with a background in phase-transfer catalysis but without specific expertise in carbon dioxide capture chemistry, I find the data compelling, but I still have questions. For example, although the inventors avoid the energy cost of a stripping step, it remains unclear how scalable or energy-efficient the overall system would be at 10 bar. Perhaps the inventors have additional data to address these questions.

In addition, the inventors are critical of the use of amines in prior art to capture the carbon dioxide, but they use amines in their reported process. I do not fully understand how easy it is to liberate the carbon dioxide from the complex with the amine. Other reports described in earlier issues of the PTC Tip of the Month do not use amines.

For readers interested in this topic, I recommend revisiting the earlier posts on CO2/epoxide systems listed at the beginning. Comparing them with the current patent provides a broader view of where PTC strategies for CO2 utilization are heading.


About Marc Halpern

Marc Halpern

Dr. Halpern is founder and president of PTC Organics, Inc., the only company dedicated exclusively to developing low-cost high-performance green chemistry processes for the manufacture of organic chemicals using Phase Transfer Catalysis. Dr. Halpern has innovated PTC breakthroughs for pharmaceuticals, agrochemicals, petrochemicals, monomers, polymers, flavors & fragrances, dyes & pigments and solvents. Dr. Halpern has provided PTC services on-site at more than 260 industrial process R&D departments in 37 countries and has helped chemical companies save > $200 million. Dr. Halpern co-authored five books including the best-selling “Phase-Transfer Catalysis: Fundamentals, Applications and Industrial Perspectives” and has presented the 2-day course “Practical Phase-Transfer Catalysis” at 50 locations in the US, Europe and Asia.

Dr. Halpern founded the journal “Industrial Phase-Transfer Catalysis” and “The PTC Tip of the Month” enjoyed by 2,100 qualified subscribers, now beyond 130 issues. In 2014, Dr. Halpern is celebrating his 30th year in the chemical industry, including serving as a process chemist at Dow Chemical, a supervisor of process chemistry at ICI, Director of R&D at Sybron Chemicals and founder and president of PTC Organics Inc. (15 years) and PTC Communications Inc. (20 years). Dr. Halpern also co-founded PTC Interface Inc. in 1989 and PTC Value Recovery Inc. in 1999. His academic breakthroughs include the PTC pKa Guidelines, the q-value for quat accessibility and he has achieved industrial PTC breakthroughs for a dozen strong base reactions as well as esterifications, transesterifications, epoxidations and chloromethylations plus contributed to more than 100 other industrial PTC process development projects.

Dr. Halpern has dedicated his adult life to his family and to phase-transfer catalysis (in that order!).

Leave a Reply

Your email address will not be published. Required fields are marked *